# Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia

> **NCT03957057** · PHASE3 · COMPLETED · sponsor: **University Medical Centre Ljubljana** · enrollment: 300 (actual)

## Conditions studied

- Postpartum Anemia Nos
- Iron-deficiency

## Interventions

- **DRUG:** Iron Carboxymaltose
- **DRUG:** Iron Isomaltoside
- **DRUG:** Ferrous sulphate

## Key facts

- **NCT ID:** NCT03957057
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-10
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-06-15
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2022-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03957057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03957057, "Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03957057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*